6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)-

Request For Quotation
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)- Suppliers list
Company Name: Cayman Chemical Company  
Tel: 800-364-9897
Email: sales@caymanchem.com
Company Name: Cayman Chemical Company  
Tel: (800) 364-9897
Email: cayman@caymanchem.com
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)- Basic information
Product Name:6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)-
Synonyms:6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)-;9(R)-Hexahydrocannabinol (CRM);9(R)-Hexahydrocannabinol
CAS:36403-90-4
MF:C21H32O2
MW:316.48
EINECS:
Product Categories:
Mol File:36403-90-4.mol
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)- Structure
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)- Chemical Properties
Boiling point 390.2±31.0 °C(Predicted)
density 0.993±0.06 g/cm3(Predicted)
solubility Acetonitrile: 10 mg/ml
pka9.94±0.60(Predicted)
Safety Information
MSDS Information
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)- Usage And Synthesis
Description9(R)-Hexahydrocannabinol (CRM) is a certified reference material that is structurally similar to known phytocannabinoids. 9(R)-Hexahydrocannabinol induces immobility, severe stupor, ataxia, full ptosis, and crouched posture, markers of psychotropic activity, in rhesus monkeys.1 This product is intended for research and forensic applications.
References[1] Mechoulam, R., Lander, N., Varkony, T.H., et al. Stereochemical requirements for cannabinoid activity J. Med. Chem. 23(10),1068-1072(1980).
[2] KARIN LINDBOM. Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples[J]. Drug Testing and Analysis, 2024, 17 3: 372-386. DOI: 10.1002/dta.3740
[3] LIESL K. JANSSENS. Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays—and how this matters for the harm potential of seized drugs[J]. Archives of Toxicology, 2024, 98 8: 2619-2630. DOI: 10.1007/s00204-024-03769-4
[4] FLORIAN PITTERL. Insights into the human metabolism of hexahydrocannabinol by non-targeted liquid chromatography-high-resolution tandem mass spectrometry.[J]. Journal of analytical toxicology, 2024: 350-358. DOI: 10.1093/jat/bkae022
[5] UJVÁRY I. Hexahydrocannabinol and closely related semi-synthetic cannabinoids: A comprehensive review[J]. Drug Testing and Analysis, 2023, 16 2: 127-161. DOI: 10.1002/dta.3519
6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)- Preparation Products And Raw materials
Tag:6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)-(36403-90-4) Related Product Information
9(S)-Hexahydrocannabinol Acetate 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9R,10aR)- 7-hydroxyhexahydrocannabinol 3-heptyl-delta(1)-tetrahydrocannabinol 9(R)-Hexahydrocannabinol-d9 6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,9,10,10a-hexahydro-6,6,9-trimethyl-3-pentyl-, (6aR,9S,10aR)-